Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06225479 · ClinicalTrials.gov registry record · NA
PRescription Exercise for Older Men With Urinary Disease
A NA study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 2
- Study locations
NCT06225479: Recruiting NA study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms, sponsored by University of California, San Francisco.
NCT06225479 is a NA study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 68 participants, below the 550-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06225479, a NA study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a single-center pilot randomized controlled trial among 68 physically "inactive" older men with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (LUTS/BPH) assessing a 12-week remote exercise intervention versus health education control.
Primary Outcome
Proportion of participants randomized of those screened (completed screening call)
Conditions Studied
Interventions
- BEHAVIORAL Exercise
- OTHER Calls and Newsletter
Study Locations (2)
California
- San Francisco VA Medical Center - San Francisco
- UCSF Health - Mission Bay Campus - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2024-01-03 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
What NCT06225479 shows while recruiting
NCT06225479 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 550-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.
NCT06225479 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06225479 about?
NCT06225479 is a clinical study titled "PRescription Exercise for Older Men With Urinary Disease". This is a single-center pilot randomized controlled trial among 68 physically "inactive" older men with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (LUTS/BPH) assessing a 12-week remote exercise intervention versus health education control.
What is the current status of trial NCT06225479?
This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-01-03. Estimated completion is 2026-04-01.
What conditions does trial NCT06225479 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms.
What interventions are being tested in trial NCT06225479?
The interventions under investigation include: Exercise (BEHAVIORAL), Calls and Newsletter (OTHER).
Who is sponsoring clinical trial NCT06225479?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06225479 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06225479's enrollment target sits among peer trials
68 23rd of 29 higher than 7 of 29 other Benign Prostatic Hyperplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Benign Prostatic Hyperplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ambulatory Long Length URodynamics Evaluation
RECRUITING · NA
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI